For Immediate Release
Baltimore MD | July 1, 2019
The Maryland Development Center is pleased to announce that MDC Client company Pneumico has been awarded a Phase I SBIR grant by the National Science Foundation. The $223,363 grant is for development of the Company’s product for monitoring the use of bag mask ventilation devices for manual resuscitation of patients.
Bag valve masks allow for manual ventilation by a caregiver when temporary ventilation support is required. They are used not only in pre-hospital transport and resuscitation, but throughout hospitals and out-of-hospital care venues. The fundamental principal behind this procedure is that a caregiver can estimate the appropriate pressure, volume and frequency of the ventilatory support simulating what a fully automated ventilator might provide. Studies show that trained personnel rarely use BVM?s appropriately with 88.4% of users exceeding the recommended pressure and 73.8% exceeding the recommended volume range. Improper BVM can not only lead to poor ventilation of a critical patient, but can directly cause both acute and long-term lung damage. Dr. Marascalchi conceived the idea for a device to support proper bag mask ventilation use and training after observing a child being injured from improper use.
Pneumico is a client company of the Maryland Development Center, and Dr. Marascalchi is an Affiliate Member of MDC. The Company, now resident at MDC, has employed MDC engineers to develop the prototype device.
“We are delighted to work with Dr. Marascalchi on the development of the Pneumico technology and the development of the Company.,” said Dr. Gil Blankenship, co-founder and CEO of MDC.
About Maryland Development Center
The Maryland Development Center is a startup studio created to commercialize intellectual property developed in Maryland’s rich research enterprises. Since its founding MDC has explored dozens of technologies, created 9 companies, and filed numerous patents. Maryland has the largest federal research budget in the United States; MDC was created to help realize some of the commercial value of the extraordinary research programs at the State’s great universities and laboratories.